Psychological factors as a predictor of treatment response in patients with heartburn: A pooled analysis of clinical trials

References

• Galmiche JP, Janssens J. The pathophysiology of gastro-oesophageal reflux disease: an overview. Scand J Gastroenterol 1995; 30 Suppl 211: 7–18
   Google Scholar
• Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996; 31 Suppl 221: 8–13
   Google Scholar
• Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998; 104: 252–8
   PubMed Web of Science ®Google Scholar
• Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046–52
   PubMed Web of Science ®Google Scholar
• Wahlqvist P, Carlsson J, Wiklund I, Stålhammar N-O. Measuring lost productivity in patients with GORD using a productivity questionnaire (WPAI-GORD). Qual Life Res 1999; 8: 576
   Google Scholar
• Wiklund I, Bardhan KD, Muller-Lissner S, Bigard MA, Bianchi Porro G, Ponce J, et al. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Ital J Gastroenterol Hepatol 1998; 30: 19–27
   PubMedGoogle Scholar
• Wiklund I, Glise H. Quality of life in different gastrointestinal conditions. Eur J Surg 1998; 164 Suppl 582: 56–61
   Google Scholar
• Glise H, Hallerbäck B, Wiklund I. Quality of life a reflection of symptoms and concerns. Scand J Gastroenterol 1996; 31 Suppl 221: 14–7
   Google Scholar
• Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96 Suppl 8: 46–53
   Google Scholar
• Dent J. Long-term aims of treatment of reflux disease, and the role of non-drug measures. Digestion 1992; 51 Suppl 1: 30–4
   PubMedGoogle Scholar
• Dent, J, Brun, J, Fendrick, AM, Fennerty, MB, Janssens, J, Kahrilas, PJ, et al. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut. 1999;44 Suppl 2:S1–16.
   Google Scholar
• Wiklund I. Aspects of quality of life in gastrointestinal disease: some methodological issues. Scand J Gastroenterol 1995; 208: 129–32
   Google Scholar
• Chiba N. Proton pump inhibitors in acute healing and maintenance of erosive or worse oesophagitis: a systematic overview. Can J Gastroenterol 1997; II Suppl B: 66B–73
   Google Scholar
• Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798–810
   PubMed Web of Science ®Google Scholar
• Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, et al. Quality of life in patients with heartburn but without oesophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999; 94: 1782–9
   PubMed Web of Science ®Google Scholar
• Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastro-oesophageal reflux disease (GORD) in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998; 10: 119–24
   PubMed Web of Science ®Google Scholar
• Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 965–73
   PubMed Web of Science ®Google Scholar
• Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastroesophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 1621–30
   PubMed Web of Science ®Google Scholar
• Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974–9
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux oesophagitis. Results from a double-blind randomized multicentre study. Scand J Gastroenterol 1988; 23: 625–32
   PubMed Web of Science ®Google Scholar
• Glise H, Hallerback B, Johansson B. Quality of life assessments in the evaluation of gastrointestinal reflux and peptic ulcer disease before, during and after treatment. Scand J Gastroenterol 1995; 30: 133–5
   PubMed Web of Science ®Google Scholar
• Glise H, Wiklund I. Measurement of the impact of heartburn and dyspepsia on quality of life. Aliment Pharmacol Ther 1997; 11: 73–7
   Google Scholar
• Dupuy HJ. The Psychological General Well-Being (PGWB) Index. Assessment of quality of life in clinical trials of cardiovascular therapies, NK Wenger, ME Mattson, CD Furbery, et al. Le Jacq Publishing Inc, New York 1984; 170–83
   Google Scholar
• Chal KL, Stacey JH, Sacks GE. The effect of ranitidine on symptom relief and quality of life in patients with gastro-oesophageal reflux disease. Br J Clin Pract 1995; 49: 73–7
   PubMedGoogle Scholar
• Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens?. Scand J Gastroenterol 1993; 28: 681–7
   PubMedGoogle Scholar
• Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, et al. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract 1995; 41: 126–36
   PubMedGoogle Scholar
• Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 1995; 90: 1797–803
   PubMed Web of Science ®Google Scholar
• Johnston BT, Lewis SA, Love AH. Psychological factors in gastro-oesophageal reflux disease. Gut 1995a; 36: 481–2
   PubMed Web of Science ®Google Scholar
• Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993; 88: 11–9
   PubMed Web of Science ®Google Scholar
• Wiklund I, Butler-Wheelhouse P. Psychosocial factors and their role in symptomatic gastroesophageal reflux disease and functional dyspepsia. Scand J Gastroenterol 1996; 31 Suppl 220: 94–100
   Google Scholar
• Johnston BT, Lewis SA, Collins JS, McFarland RJ, Love AH. Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol 1995b; 30: 1–5
   PubMed Web of Science ®Google Scholar
• Lydeard S, Jones RH. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495–8
   PubMedGoogle Scholar
• Crawley, JA, Hamelin, B, Gallagher, E. Does it matter why heartburn sufferers seek healthcare?. Gastroenterology 2000;118 Suppl 2:A209, [abstract].
   Google Scholar
• Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18: 767–76
   PubMed Web of Science ®Google Scholar
• Axelrod DA, Divi V, Ajluni MM, Eckhauser FE, Colletti LM. Influence of functional bowel disease on outcome of surgical antireflux procedures. J Gastrointest Surg 2002; 6: 632–7
   PubMedGoogle Scholar